Immunohistochemical results showed that PAD4 was significantly upregulated in the malignant tissues and blood of patients with PHC, including HCC and intrahepatic cholangiocarcinoma (ICC) [28,29,243]. This evidence concerns the gene PADI4 and hepatocellular carcinoma.